Publication date: Sep 04, 2024
With the outbreak and continued spread of the COVID-19 pandemic, people’s demand for daily disinfection products has increased rapidly, and its innovative design has received widespread attention. In this context, this study aims to propose a design methodology for home entrance disinfection devices based on AHP-FAST-FBS. Firstly, the design requirements of the home entrance disinfection device were collected and analyzed through in-depth interviews and the KJ method, and a hierarchical model of design demand indicators was constructed. Secondly, the Analytical Hierarchy Process (AHP) was employed to quantify these design demand indicators, and core design demands for home entrance disinfection devices were identified by weight calculations. On this basis, the Functional Analysis System Technique (FAST) method was combined to rationally transform the design demands into product functional indicators, constructing a functional system model for the home entrance disinfection device through systematic decomposition and categorization. Lastly, based on the Function-Behavior-Structure (FBS) theoretical model, the mapping of each function of the product to its structure was realized, the product structure modules were determined, and the comprehensive design and output of the innovative design scheme for the home entrance disinfection device were completed. The results of this study indicate that the design methodology combining AHP-FAST-FBS can effectively improve the scientific rigor and effectiveness of the home entrance disinfection device design, thereby generating an ideal product design scheme. This study provides systematic theoretical guidance and practical reference for designers of subsequent related disinfection products and also offers a new path for improving social health and safety.
Open Access PDF
Concepts | Keywords |
---|---|
Daily | COVID-19 |
Designers | Disinfection |
Disinfection | Humans |
Home | Models, Theoretical |
Rapidly | Pandemics |
SARS-CoV-2 |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
disease | IDO | process |
drug | DRUGBANK | Coenzyme M |
drug | DRUGBANK | Troleandomycin |
disease | IDO | production |
disease | MESH | home environment |
disease | MESH | virus infection |
disease | MESH | uncertainty |
disease | MESH | privacy |
drug | DRUGBANK | Aspartame |
disease | IDO | bacteria |
drug | DRUGBANK | Iodide I-123 |
disease | MESH | aids |
disease | IDO | susceptibility |
disease | IDO | country |
drug | DRUGBANK | Pidolic Acid |
drug | DRUGBANK | Trestolone |
disease | IDO | algorithm |
drug | DRUGBANK | Nonoxynol-9 |
disease | MESH | decompression sickness |
drug | DRUGBANK | Diethylstilbestrol |
drug | DRUGBANK | Isoxaflutole |
drug | DRUGBANK | Tromethamine |
drug | DRUGBANK | (S)-Des-Me-Ampa |
drug | DRUGBANK | Serine |
disease | MESH | rhinitis |
pathway | REACTOME | Reproduction |